TSIVGOULIS, G., A.H. KATSANOS, P. KADLECOVA, A. CZLONKOWSKA, A. KOBAYASHI, M. BROZMAN, V. SVIGELJ, L. CSIBA, K. FEKETE, J. KORV, V. DEMARIN, A. VILIONSKIS, D. JATUZIS, Y. KRESPI, C. LIANTINIOTI, S. GIANNOPOULOS a Robert MIKULÍK. Intravenous thrombolysis for ischemic stroke in the golden hour: propensity-matched analysis from the SITS-EAST registry. European Journal of Neurology. HEIDELBERG: SPRINGER HEIDELBERG, 2017, roč. 264, č. 5, s. 912-920. ISSN 0340-5354. Dostupné z: https://dx.doi.org/10.1007/s00415-017-8461-8.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Intravenous thrombolysis for ischemic stroke in the golden hour: propensity-matched analysis from the SITS-EAST registry
Autoři TSIVGOULIS, G. (300 Řecko), A.H. KATSANOS (300 Řecko), P. KADLECOVA (203 Česká republika), A. CZLONKOWSKA (616 Polsko), A. KOBAYASHI (616 Polsko), M. BROZMAN (703 Slovensko), V. SVIGELJ (705 Slovinsko), L. CSIBA (348 Maďarsko), K. FEKETE (233 Estonsko), J. KORV (233 Estonsko), V. DEMARIN (191 Chorvatsko), A. VILIONSKIS (440 Litva), D. JATUZIS (440 Litva), Y. KRESPI (792 Turecko), C. LIANTINIOTI (300 Řecko), S. GIANNOPOULOS (300 Řecko) a Robert MIKULÍK (203 Česká republika, garant, domácí).
Vydání European Journal of Neurology, HEIDELBERG, SPRINGER HEIDELBERG, 2017, 0340-5354.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30210 Clinical neurology
Stát vydavatele Německo
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 3.783
Kód RIV RIV/00216224:14110/17:00100262
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1007/s00415-017-8461-8
UT WoS 000400617200011
Klíčová slova anglicky Intravenous thrombolysis; Acute ischemic stroke; Golden hour; Onset-to-treatment time; Mobile stroke unit
Štítky EL OK
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Soňa Böhmová, učo 232884. Změněno: 26. 4. 2018 10:38.
Anotace
As there are scarce data regarding the outcomes of acute ischemic stroke (AIS) patients treated with intravenous thrombolysis (IVT) within 60 min from symptom onset ("golden hour"), we sought to compare outcomes between AIS patients treated within [GH(+)] and outside [GH(-)] the "golden hour" by analyzing propensity score matched data from the SITS-EAST registry. Clinical recovery (CR) at 2 and 24 h was defined as a reduction of ae10 points on NIHSS-score or a total NIHSS-score of ae3 at 2 and 24 h, respectively. A relative reduction in NIHSS-score of ae40% at 2 h was considered predictive of complete recanalization (CREC). Symptomatic intracranial hemorrhage (sICH) was defined using SITS-MOST criteria. Favorable functional outcome (FFO) was defined as a mRS-score of 0-1 at 3 months. Out of 19,077 IVT-treated AIS patients, 71 GH(+) patients were matched to 6882 GH(-) patients, with no differences in baseline characteristics (p > 0.1). GH(+) had higher rates of CR at 2 (31.0 vs. 12.4%; p < 0.001) and 24 h (41 vs. 27%; p = 0.010), CREC at 2 h (39 vs. 21%; p < 0.001) and FFO (46.5 vs. 34.0%; p = 0.028) at 3 months. The rates of sICH and 3-month mortality did not differ (p > 0.2) between the two groups. GH(+) was associated with 2-h CR (OR: 5.34; 95% CI 2.53-11.03) and CREC (OR: 2.38; 95% CI 1.38-4.09), 24-h CR (OR: 1.88; 95% CI 1.08-3.26) and 3-month FFO (OR: 2.02; 95% CI 1.15-3.54) in multivariable logistic regression models adjusting for potential confounders. In conclusion, AIS treated with IVT within the GH seems to have substantially higher odds of early neurological recovery, CREC, 3-month FFO and functional improvement.
VytisknoutZobrazeno: 14. 5. 2024 01:08